Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Hisse Senetlerindeki Sıralama #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Hisse Fiyatı
$25.28
Son senkronizasyon: 2026-09-18
Piyasa Değeri
$1.01B
Değişim (1 gün)
-2.29%
Değişim (1 yıl)
-37.84%
Ülke
GB
Ticaret GSK plc (GSK)

Kategori

GSK plc (GSK) için kazanç
Jun 2026 itibarıyla kazanç TTM: $8.03B
GSK plc şirketinin en son finansal raporlarına göre, mevcut kazancı $8.03B'dir. 2024 yılında şirket $4.36B kazanç elde etti, bu 2023 yılındaki $7.72B kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
GSK plc için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $8.03B -17.47%
2025 $9.73B 123.11%
2024 $4.36B -43.48%
2023 $7.72B 13.38%
2022 $6.81B 39.93%
2021 $4.87B -31.16%
2020 $7.07B -14.32%
2019 $8.25B 34.93%
2018 $6.11B 28.34%
2017 $4.76B 99.06%
2016 $2.39B -84.57%
2015 $15.51B 235.45%
2014 $4.62B -58.00%
2013 $11.01B 2.83%
2012 $10.71B -10.38%
2011 $11.95B 143.12%
2010 $4.91B -61.53%
2009 $12.77B 31.37%
2008 $9.72B -35.26%
2007 $15.02B -1.77%
2006 $15.29B 31.99%
2005 $11.58B 4.33%
2004 $11.10B -1.73%
2003 $11.30B 27.36%
2002 $8.87B 0.26%
2001 $8.85B -1.72%
2000 $9.00B 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$33.59B 318.17%
US
$25.20B 213.63%
US
$8.70B 8.28%
US
$21.39B 166.24%
CH
$5.95B -25.96%
US